View in EDS HTML Full Text PDF Full Text

The SGLT2 Inhibitor Dapagliflozin Disrupts the Cell Cycle at High Concentrations Without Altering Glycosphingolipid (De Novo)Biosynthesis.

Saved in:
Bibliographic Details
Title: The SGLT2 Inhibitor Dapagliflozin Disrupts the Cell Cycle at High Concentrations Without Altering Glycosphingolipid (De Novo)Biosynthesis.
Authors: Jennemann, Richard1 (AUTHOR) r.jennemann@dkfz.de, Sandhoff, Roger1 (AUTHOR)
Source: International Journal of Molecular Sciences. Oct2025, Vol. 26 Issue 19, p9811. 14p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:16616596
DOI:10.3390/ijms26199811